These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 34766876

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
    Zhao H, Liu J, He L, Zhang L, Yu R, Kang C.
    Biochem Biophys Res Commun; 2022 Oct 20; 626():114-120. PubMed ID: 35988295
    [Abstract] [Full Text] [Related]

  • 23. Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.
    Jiang Y, Liu L, Manning M, Bonahoom M, Lotvola A, Yang Z, Yang ZQ.
    J Biomol Struct Dyn; 2022 Feb 20; 40(3):1331-1346. PubMed ID: 33016237
    [Abstract] [Full Text] [Related]

  • 24. The Chameleon Strategy-A Recipe for Effective Ligand Screening for Viral Targets Based on Four Novel Structure-Binding Strength Indices.
    Latosińska M, Latosińska JN.
    Viruses; 2024 Jul 03; 16(7):. PubMed ID: 39066235
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
    Wang Y, Sun Y, Wu A, Xu S, Pan R, Zeng C, Jin X, Ge X, Shi Z, Ahola T, Chen Y, Guo D.
    J Virol; 2015 Aug 03; 89(16):8416-27. PubMed ID: 26041293
    [Abstract] [Full Text] [Related]

  • 27. Despite the odds: formation of the SARS-CoV-2 methylation complex.
    Matsuda A, Plewka J, Rawski M, Mourão A, Zajko W, Siebenmorgen T, Kresik L, Lis K, Jones AN, Pachota M, Karim A, Hartman K, Nirwal S, Sonani R, Chykunova Y, Minia I, Mak P, Landthaler M, Nowotny M, Dubin G, Sattler M, Suder P, Popowicz GM, Pyrć K, Czarna A.
    Nucleic Acids Res; 2024 Jun 24; 52(11):6441-6458. PubMed ID: 38499483
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Novel Inhibitors of 2'-O-Methyltransferase of the SARS-CoV-2 Coronavirus.
    Sulimov A, Kutov D, Ilin I, Xiao Y, Jiang S, Sulimov V.
    Molecules; 2022 Apr 23; 27(9):. PubMed ID: 35566072
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases.
    Samrat SK, Bashir Q, Zhang R, Huang Y, Liu Y, Wu X, Brown T, Wang W, Zheng YG, Zhang QY, Chen Y, Li Z, Li H.
    Emerg Microbes Infect; 2023 Dec 23; 12(1):2204164. PubMed ID: 37060263
    [Abstract] [Full Text] [Related]

  • 34. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
    Mohammad A, Alshawaf E, Marafie SK, Abu-Farha M, Al-Mulla F, Abubaker J.
    Biomolecules; 2021 Apr 14; 11(4):. PubMed ID: 33919870
    [Abstract] [Full Text] [Related]

  • 35. Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening.
    Bobrovs R, Kanepe I, Narvaiss N, Patetko L, Kalnins G, Sisovs M, Bula AL, Grinberga S, Boroduskis M, Ramata-Stunda A, Rostoks N, Jirgensons A, Tars K, Jaudzems K.
    Pharmaceuticals (Basel); 2021 Nov 30; 14(12):. PubMed ID: 34959647
    [Abstract] [Full Text] [Related]

  • 36. Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues.
    Ahmed-Belkacem R, Hausdorff M, Delpal A, Sutto-Ortiz P, Colmant AMG, Touret F, Ogando NS, Snijder EJ, Canard B, Coutard B, Vasseur JJ, Decroly E, Debart F.
    J Med Chem; 2022 Apr 28; 65(8):6231-6249. PubMed ID: 35439007
    [Abstract] [Full Text] [Related]

  • 37. High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design.
    Rosas-Lemus M, Minasov G, Shuvalova L, Inniss NL, Kiryukhina O, Brunzelle J, Satchell KJF.
    Sci Signal; 2020 Sep 29; 13(651):. PubMed ID: 32994211
    [Abstract] [Full Text] [Related]

  • 38. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
    Silva JRA, Urban J, Araújo E, Lameira J, Moliner V, Alves CN.
    Int J Mol Sci; 2021 Dec 28; 23(1):. PubMed ID: 35008724
    [Abstract] [Full Text] [Related]

  • 39. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs.
    Eissa IH, Alesawy MS, Saleh AM, Elkaeed EB, Alsfouk BA, El-Attar AMM, Metwaly AM.
    Molecules; 2022 Mar 31; 27(7):. PubMed ID: 35408684
    [Abstract] [Full Text] [Related]

  • 40. Structural basis of RNA cap modification by SARS-CoV-2.
    Viswanathan T, Arya S, Chan SH, Qi S, Dai N, Misra A, Park JG, Oladunni F, Kovalskyy D, Hromas RA, Martinez-Sobrido L, Gupta YK.
    Nat Commun; 2020 Jul 24; 11(1):3718. PubMed ID: 32709886
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.